Big Director Buys At British American Tobacco Plc, Reckitt Benckiser Group Plc And Goals Soccer Centres plc

Directors have splashed the cash at British American Tobacco Plc (LON:BATS), Reckitt Benckiser Group Plc (LON:RB) and Goals Soccer Centres plc (LON:GOAL).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Directors at British American Tobacco (LSE: BATS) (NYSE: BTI.US), Reckitt Benckiser (LSE: RB) and Goals Soccer Centres (LSE: GOAL) splashed out this Christmas — on buying shares in their own companies.

At what price were these directors happy to treat themselves, and how much did they invest? Read on!

Goals Soccer Centres

Goals Soccer Centres, a £127m AIM-listed company, is the UK’s leading five-a-side football chain with 44 sites around the country.

Philip Burks, who co-founded self-storage firm Big Yellow Group, joined Goals as a non-executive director at the start of 2011. Up until recently, Burks had made relatively small annual purchases of Goals shares. However, in the last few months he’s massively upped his buying. A £240,000 investment on 22 December was the culmination of four separate purchases, totalling almost £0.7m.

Burks’s average buy price was 218p, but you’ll have to pay a bit more than that today. The shares currently trade at 235p — or 14 times 2015 forecast earnings.

Reckitt Benckiser

Another director who bought himself a £0.7m present of company shares was Reckitt Benckiser’s chief financial officer, Adrian Hennah. Hennah, who was poached from medical devices firm Smith & Nephew two years ago, bought 13,222 Reckitt shares at 5,177p a pop, doubling his previous holding at one fell swoop.

The share price is at around the same level today and represents a hefty 20 times Reckitt’s 2015 forecast earnings. However, you’ll miss out on a benefit Hennah and other shareholders at the time enjoyed. The CFO bought his shares before Reckitt demerged its pharmaceuticals business on 23 December, and, as such, automatically received shares in the new company, Indivior, currently worth 149p. Effectively, then, an investor today would need to buy Reckitt shares at 5,028p (5,177p minus 149p) to match Hennah’s deal.

British American Tobacco

British American Tobacco chairman Richard Burrows rounded off 2014 with a New Year’s Eve purchase of 5,000 company shares at 3,520p a time. The £176,000 investment took his total holding to 15,000 shares.

Burrows, a former chief executive of Pernod Ricard, who joined British American Tobacco in 2009, was happy to pay 16 times BAT’s 2015 forecast earnings and bag a dividend yield of 4.5%. You can pick the shares up slightly cheaper today at 3,460p.

G A Chester has no position in any shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Here’s how investors can aim for £11,363 a year in passive income from £20,000 in this overlooked FTSE media gem

I think this media stock is commonly overlooked by investors looking for high passive income, but it shouldn’t be, given…

Read more »

Tesla car at super charger station
Investing Articles

Why is Tesla stock down 30% since late 2025?

Tesla stock has been a bit of a car crash in 2026. Edward Sheldon looks at what’s going on, and…

Read more »

UK supporters with flag
Investing Articles

Is Wise now the UK stock market’s top growth share?

Wise rose around 4% in the UK stock market yesterday, bringing its four-year gain to 135%. Why are investors warming…

Read more »

Warhammer World gathering
Investing Articles

£20,000 invested in this FTSE 100 stock 10 years ago is now worth this astonishing amount…

This FTSE 100 stock's delivered an amazing return over the past 10 years. James Beard considers whether it’s worth holding…

Read more »